During this CME-certified presentation, expert faculty will discuss the strengths and limitations of the first generation of NNRTIs, review clinical studies of next-generation NNRTIs, and provide insightful strategies on how best to utilize next-generation agents in clinical practice.
Registration for this activity is open to physicians and healthcare professionals actively involved in the delivery of care to HIV-infected patients. Other restrictions may apply.
Program Overview
You are invited to an in-depth CME-certified Grand Rounds presentation led by expert faculty in the field of HIV care. The topics covered include:
- A review of the strengths and weaknesses of the first-generation NNRTIs
- A discussion of the clinical impact of emergent and transmitted NNRTI resistance on the first- and second-generation agents in this class
- An overview of clinical data from studies investigating the next-generation NNRTIs
- Clinical strategies on how best to utilize next-generation NNRTIs in combination with currently approved agents as well as those in expanded access programs
Purpose
The purpose of this activity is for participants to learn about clinical strategies to maximize the effectiveness of next-generation NNRTI agents in the management of treatment-experienced HIV-infected patients.
Target Audience
This activity is designed as a state-of-art curriculum for physicians, registered nurses, pharmacists, and other healthcare professionals involved in the management of HIV-infected patients.
Learning Objectives
-
Summarize recent clinical data on the safety and efficacy of next-generation NNRTIs
-
Describe the impact of NNRTI resistance mutations on response to both currently FDA-approved NNRTIs and next-generation NNRTIs
-
Discuss the use of investigational or recently approved agents in combination with currently approved therapies to maximize outcomes in treatment-experienced HIV-infected patients